We came across a bullish thesis on Amgen Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.'s share was trading at $325.54 as of January 12th. AMGN’s trailing and forward P/E were 25.18 and 14.79 respectively according to Yahoo Finance. Copyright: lightwise / 123RF Stock Photo Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide and has seen a steady recovery in 2025, with shares recently t ...